Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium
NCT01241058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257
Last updated 2016-01-20
Summary
A registry of pediatric patients (under 18 yrs of age) diagnosed with Crohn's disease was created in Belgium. Over a 2 year period 257 patients are included. These patients will be follow up prospectively during 5 years. Demographic data, family history, disease presentation and disease course including medication are registered in CRF's.
Conditions
- Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations
Sponsors & Collaborators
-
Gigi Veereman
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- Belgium
Study Locations
More Related Trials
-
Pediatric Penetrating Crohn's Disease
NCT04119635 ·Status: COMPLETED
-
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
NCT04283864 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
NCT03017014 ·Status: TERMINATED
-
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
NCT02421705 ·Status: RECRUITING ·Phase: NA
-
Diet in Pediatric Crohn´s Disease Treated With Biologics
NCT05034458 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
NCT06581042 ·Status: RECRUITING
-
Pain in Patients With Crohn Disease (PAINCD)
NCT04488146 ·Status: UNKNOWN
-
Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
NCT07314606 ·Status: RECRUITING ·Phase: NA
-
Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
NCT02450513 ·Status: COMPLETED
-
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
NCT02130362 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152 ·Status: RECRUITING ·Phase: PHASE4
-
Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease
NCT06796959 ·Status: COMPLETED
-
Remicade® Crohn's Disease Registry Across Canada (Study P02793)
NCT00755937 ·Status: TERMINATED
-
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
NCT02425111 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease
NCT00207675 ·Status: COMPLETED ·Phase: PHASE3
-
Early MRI Prediction of Crohns
NCT03340519 ·Status: COMPLETED
-
Evaluation of Stricturing Crohn's Disease Using Digital Holographic Microscopy
NCT03465215 ·Status: UNKNOWN ·Phase: NA
-
Top-down Infliximab Study in Kids With Crohn's Disease
NCT02517684 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of TRK-170 for the Treatment of Crohn's Disease
NCT01345799 ·Status: COMPLETED ·Phase: PHASE2
-
Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
NCT04032756 ·Status: TERMINATED
-
Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease
NCT01559142 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease
NCT01671579 ·Status: TERMINATED ·Phase: NA
-
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346 ·Status: ACTIVE_NOT_RECRUITING
-
Real World Evidence Study With Restrictive Diet and Otral Nutritional Supplementation on Pediatric Patients With Active Chron Disease
NCT07211789 ·Status: COMPLETED
-
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403 ·Status: COMPLETED